Bharat Parenterals Ltd.

View in App
1255.00 -67.95 ▼-5.1%

19 April 2024, 10:10:00 AM
Volume: 475

Company Profile

View details >>
Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.bplindia.in
Market Cap 769.91 Cr.
Enterprise Value(EV) 855.72 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 49.50 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 26.72 Trailing Twelve Months Ending 2023-12
Industry PE 41.01 Trailing Twelve Months Ending 2023-12
Book Value / Share 362.89 Trailing Twelve Months Ending 2023-12
Price to Book Value 3.65 Calculated using Price: 1,322.95
Dividend Yield 0.06 Period Ending 2023-03
No. of Shares Subscribed 0.58 Cr. 5,819,666 Shares
FaceValue 10
About Bharat Parenterals Ltd.
The company is engaged in to the business of the Pharmaceuticals & Drugs.

Bharat Parenterals Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Bharat Parenterals Ltd. Performance

View details >>
1 Day
-5.14%
1 Week
-8.38%
1 Month
+7.77%
3 Month
+63.09%
6 Month
+106.69%
1 Year
+278.01%
2 Year
+231.09%
5 Year
+497.62%
10 Year

Bharat Parenterals Ltd. Fundamental Ratios

View details >>
9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 16.04 12.1 12.21 14.59 26.38 23.92 15.16 13.76 13.65
Return on Capital Employed (%) 16.65 15.21 12.09 19.15 39.83 31.68 19.8 17.59 16.62
Return on Assets (%) 6.85 5.46 6.41 8.37 15.44 14.88 10.4 10.29 9.25

Bharat Parenterals Ltd. Balance Sheet

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 50 57 64 74 97 123 144 166 191 206
Non Curr. Liab. 13 7 3 0 4 3 11 12 9 7
Curr. Liab. 53 56 43 57 60 66 41 40 108 139
Minority Int.
Equity & Liab. 116 120 110 131 161 192 196 218 308 353
Non Curr. Assets 43 49 46 39 41 56 49 75 134 154
Curr. Assets 73 72 64 92 120 136 147 143 175 199
Misc. Exp. not W/O
Total Assets 116 120 110 131 161 192 196 218 308 353

Bharat Parenterals Ltd. Profit and Loss

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 119 124 111 136 220 226 204 212 218 239
Other Income 4 5 8 7 13 12 9 8 19 16
Total Income 123 129 119 144 232 238 212 220 237 255
Total Expenditure -108 -114 -104 -123 -190 -197 -179 -184 -196 -208
PBIDT 15 15 15 20 43 42 34 36 41 47
Interest -2 -1 -1 -1 -1 -1 -1 -1 -3 -3
Depreciation -4 -4 -6 -6 -6 -6 -6 -7 -6 -6
Taxation -1 -3 -1 -4 -13 -9 -7 -7 -8 -9
Exceptional Items
PAT 7 6 7 10 23 26 20 21 24 29
Adjusted EPS 13 11 13 18 39 46 35 37 42 50

Bharat Parenterals Ltd. Cash Flow

View details >>
Particulars 8 years 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. -2 6 20 14 22 -22 -12
Cash Fr. Inv. -2 -8 -9 -13 -41 22 -14
Cash Fr. Finan. -8 4 -4 -3 11 2 29
Net Change -11 2 7 -1 -8 2 3
Cash & Cash Eqvt 2 4 11 10 1 3 6

Bharat Parenterals Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%)
Promoter 74.42 73.84 73.84 73.84 73.84 73.84 73.84 73.84 73.84
Public 25.58 26.16 26.16 26.16 26.16 26.16 26.16 26.16 26.16
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
No. of Shareholders (in Lacs)

Bharat Parenterals Ltd. Announcements

View details >>
Thu, 18 Apr 2024
Compliance Certificate For The Year Ended On 31St March 2024 Certifying That All Certificates Are Issued Within 30Days Of Date Of Lodgment Of Transfer Transimission Sub-Division Cosolidation Etc
Compalinace certificat for year ended o 31st Mach 2024 under regulation 40(9)
Sat, 13 Apr 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Intimation under regulation 74(5) of SEBI(Depositories and Participants) Regulations 2018 for period ended on 31st March 2024.
Sat, 13 Apr 2024
Compliances-Compliance Certificate For The Period Ended March 2024.
Compliance Certificate for the year ended on 31st March 2024 related to share transfer facility.

Bharat Parenterals Ltd. Technical Scans

View details >>
Thu, 18 Apr 2024
High Delivery Percentage High Delivery Percentage
Close Within 52 Week High Zone Close Within 52 Week High Zone
High Increase in 1 Month High Increase in 1 Month
High Increase in 3 Months High Increase in 3 Months
High Increase in 6 Months High Increase in 6 Months

Bharat Parenterals Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 364,015.10 1,509.25 -0.5%
Cipla Ltd. 108,808.58 1,342.25 -0.4%
Dr. Reddy's Laboratories Ltd. 99,408.67 5,931.65 -0.4%
Divi's Laboratories Ltd. 98,683.96 3,673.40 -1.0%
Mankind Pharma Ltd. 96,037.07 2,376.05 -0.8%
Zydus Lifesciences Ltd. 94,213.69 931.40 -0.6%
Apollo Hospitals Enterprise Ltd. 87,250.69 6,131.50 +0.9%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 40.87 1,509.25 -0.5%
Cipla Ltd. Consolidated 2023-12 29.34 1,342.25 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 19.01 5,931.65 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-12 71.36 3,673.40 -1.0%
Mankind Pharma Ltd. Consolidated 2023-12 55.61 2,376.05 -0.8%
Zydus Lifesciences Ltd. Consolidated 2023-12 31.68 931.40 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 110.54 6,131.50 +0.9%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.83 1,509.25 -0.5%
Cipla Ltd. Consolidated 2023-12 4.20 1,342.25 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.70 5,931.65 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-12 7.57 3,673.40 -1.0%
Mankind Pharma Ltd. Consolidated 2023-12 10.81 2,376.05 -0.8%
Zydus Lifesciences Ltd. Consolidated 2023-12 5.00 931.40 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 12.92 6,131.50 +0.9%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,509.25 -0.5%
Cipla Ltd. Consolidated 2023-03 0.02 1,342.25 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,931.65 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,673.40 -1.0%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 2,376.05 -0.8%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 931.40 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,131.50 +0.9%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,509.25 -0.5%
Cipla Ltd. Consolidated 2023-03 12.85 1,342.25 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,931.65 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,673.40 -1.0%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,376.05 -0.8%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 931.40 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,131.50 +0.9%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,509.25 -0.5%
Cipla Ltd. Consolidated 2023-03 12.85 1,342.25 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,931.65 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,673.40 -1.0%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,376.05 -0.8%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 931.40 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,131.50 +0.9%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,509.25 -0.5%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,342.25 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,931.65 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,673.40 -1.0%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 2,376.05 -0.8%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 931.40 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,131.50 +0.9%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,509.25 -0.5%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,342.25 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,931.65 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,673.40 -1.0%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 2,376.05 -0.8%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 931.40 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,131.50 +0.9%

Bharat Parenterals Ltd. FAQ's

What is Bharat Parenterals share price?
Can I buy Bharat Parenterals shares now?
What is the Dividend Yield of Bharat Parenterals?
What is the Market Cap of Bharat Parenterals?
What are the key metrics to analyse Bharat Parenterals?
What is the 52 Week High and Low of Bharat Parenterals?
What is the trend of Bharat Parenterals share price?